- Home
- OBIO vs WBX Comparison
OBIO vs WBX Comparison
Compare OBIO & WBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- WBX
- Stock Information
- Founded
- OBIO 2017
- WBX 2015
- Country
- OBIO United States
- WBX Spain
- Employees
- OBIO N/A
- WBX N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- WBX Industrial Specialties
- Sector
- OBIO Health Care
- WBX Consumer Discretionary
- Exchange
- OBIO Nasdaq
- WBX Nasdaq
- Market Cap
- OBIO 118.8M
- WBX 104.7M
- IPO Year
- OBIO N/A
- WBX N/A
- Fundamental
- Price
- OBIO $2.57
- WBX $4.36
- Analyst Decision
- OBIO Strong Buy
- WBX Buy
- Analyst Count
- OBIO 4
- WBX 4
- Target Price
- OBIO $14.00
- WBX $10.50
- AVG Volume (30 Days)
- OBIO 403.6K
- WBX 21.0K
- Earning Date
- OBIO 08-12-2025
- WBX 07-31-2025
- Dividend Yield
- OBIO N/A
- WBX N/A
- EPS Growth
- OBIO N/A
- WBX N/A
- EPS
- OBIO N/A
- WBX N/A
- Revenue
- OBIO $2,944,000.00
- WBX $173,788,608.00
- Revenue This Year
- OBIO $20.47
- WBX N/A
- Revenue Next Year
- OBIO $11.45
- WBX $36.47
- P/E Ratio
- OBIO N/A
- WBX N/A
- Revenue Growth
- OBIO 41.61
- WBX N/A
- 52 Week Low
- OBIO $2.37
- WBX $4.15
- 52 Week High
- OBIO $7.04
- WBX $31.80
- Technical
- Relative Strength Index (RSI)
- OBIO 40.46
- WBX 45.98
- Support Level
- OBIO $2.50
- WBX $4.15
- Resistance Level
- OBIO $2.75
- WBX $4.77
- Average True Range (ATR)
- OBIO 0.18
- WBX 0.34
- MACD
- OBIO -0.03
- WBX -0.22
- Stochastic Oscillator
- OBIO 11.47
- WBX 10.98
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.